Divergent clinical and immunologic outcomes based on STK11 co-mutation status in resectable KRAS-mutant lung cancers following neoadjuvant immune checkpoint blockade by Rosner, Samuel, Connor, Sydney, Sanber, Khaled, Zahurak, Marianna, Zhang, Tianbei, Gurumurthy, Isha, Zeng, Zhen, Presson, Brad, Singh, Dipika, Rayes, Roni, Sivapalan, Lavanya, Pereira, Gavin, Ji, Zhicheng, Thummalapalli, Rohit, Reuss, Joshua E, Broderick, Stephen R, Jones, David R, Deutsch, Julie S, Cottrell, Tricia R, Chaft, Jamie, Spicer, Jonathan, Taube, Janis, Anagnostou, Valsamo, Brahmer, Julie R, Pardoll, Drew M, Ji, Hongkai, Forde, Patrick M, Marrone, Kristen A, Smith, Kellie N

Get full text